Vizilite Plus
One person dies every hour from oral cancer in the United States—and the mortality has remained unchanged for more than 40 years. Alarmingly, more than 25% of oral cancer victims have no lifestyle risk factors. Clinical studies have determined that using ViziLite after the standard oral cancer examination improves the clinician’s ability to identify, evaluate and monitor suspicious areas at their earliest stages. Early detection of pre-cancerous tissue can minimize or eliminate the potentially disfiguring effects of oral cancer and possibly save your life. Proven screening technologies such as a mammogram, Pap smear, PSA and colonoscopy offer the same types of early detection of cancer. ViziLite is an easy and painless examination that gives this practice the best chance to find any oral abnormalities you may have at the earliest possible stage. This technology is the only FDA-cleared device for the identification and monitoring of oral abnormalities that could lead to cancer.
The exam consists of rinsing with a raspberry flavored solution for 30-60 seconds and the doctor scans the mouth with the ViziLite, looking for any possible abnormalities that would appear white.